Tilray Brands (NASDAQ:TLRY) & Trulieve Cannabis (NYSE:TRLV) Critical Comparison

Tilray Brands (NASDAQ:TLRY) and Trulieve Cannabis (NYSE:TRLV) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Analyst Ratings

This is a breakdown of recent recommendations for Tilray Brands and Trulieve Cannabis, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	2	2	3	1	2.38
Trulieve Cannabis	1	1	1	0	2.00

Tilray Brands presently has a consensus target price of $5.90, indicating a potential upside of 80.43%. Trulieve Cannabis has a consensus target price of $15.00, indicating a potential upside of 47.78%. Given Tilray Brands’ stronger consensus rating and higher possible upside, equities analysts plainly believe Tilray Brands is more favorable than Trulieve Cannabis.

Valuation & Earnings

This table compares Tilray Brands and Trulieve Cannabis”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$915.45 million	0.49	-$121.40 million	($1.40)	-2.34
Trulieve Cannabis	$1.18 billion	1.65	-$116.38 million	$0.11	92.27

Trulieve Cannabis has higher revenue and earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Trulieve Cannabis, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

9.3% of Tilray Brands shares are owned by institutional investors. 1.6% of Tilray Brands shares are owned by company insiders. Comparatively, 3.8% of Trulieve Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Tilray Brands and Trulieve Cannabis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-16.91%	-10.39%	-7.38%
Trulieve Cannabis	-41.55%	-4.24%	-1.72%

Summary

Trulieve Cannabis beats Tilray Brands on 7 of the 13 factors compared between the two stocks.

About Tilray Brands

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

About Trulieve Cannabis

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of May 5, 2021, the company operated through 87 dispensaries in the United States. The company is headquartered in Quincy, Florida.